Therapeutic Device Contract Manufacturing Market (2025 - 2033)

Therapeutic Device Contract Manufacturing Market Summary

The global therapeutic device contract manufacturing market size was valued at USD 53.66 billion in 2024 and is projected to reach USD 159.76 billion by 2033, growing at a CAGR of 13.15% from 2025 to 2033. The market is driven by the increasing demand for advanced therapeutic devices, the rising trend of manufacturing outsourcing by medical device companies to reduce costs and accelerate time-to-market, and the growing prevalence of chronic diseases requiring innovative treatment solutions.

Technological Advancements

The industry is witnessing rapid growth driven by significant technological advancements in manufacturing processes. Innovations such as additive manufacturing (3D printing), precision CNC machining, microfabrication, and advanced molding techniques are enabling CMOs to produce highly complex and patient-specific devices with greater accuracy and shorter lead times. The integration of electronic components, sensors, and wearable technologies into therapeutic devices has further increased the demand for sophisticated assembly and quality control processes. In addition, automation, AI-driven process monitoring, and real-time data analytics are improving production efficiency, reducing defects, and ensuring compliance with stringent regulatory standards like ISO 13485 and FDA requirements. These technological developments not only enhance product quality but also enable CMOs to offer customized, high-value solutions, creating a competitive advantage and opening new growth opportunities in both developed and emerging markets.

Product Insights

On the basis of product, the market is segmented into Class I, Class II, and Class III. The class II segment held the largest market share of 81.25% in 2024. The growth is primarily attributable to the increasing prevalence of moderately complex therapeutic devices such as infusion pumps, diagnostic imaging equipment, and orthopedic devices, which typically fall under Class II classification. These devices require moderate regulatory oversight, making them easier to manufacture and bring to market while offering substantial revenue opportunities for contract manufacturers.

On the other hand, the Class I segment is expected to witness considerable growth owing to the increasing demand for low-risk, essential therapeutic devices such as surgical instruments, bandages, and basic medical disposables. These devices have simpler regulatory requirements and lower manufacturing complexity, making them highly attractive for contract manufacturing, especially for startups and small- to mid-sized medical device companies.

Services Insights

On the basis of the services, the market is segmented into accessories manufacturing, assembly manufacturing, component manufacturing, device manufacturing, packaging and labeling, and others. The accessories manufacturing segment held the largest share in 2024. The market dominance is due to the high demand for complementary components and add-on devices that support therapeutic devices, such as catheters, tubing sets, connectors, and sensor attachments. These accessories are essential for the proper functioning and usability of primary therapeutic devices, making them a recurring revenue source for contract manufacturers. Additionally, the production of accessories often involves standardized processes with moderate regulatory oversight, enabling CMOs to achieve high-volume production efficiently.

Moreover, device manufacturing segments are anticipated to grow at the highest CAGR during the forecast period. The segment's growth is due to the rising demand for fully assembled, high-value therapeutic devices, including implantable, infusion pumps, and wearable medical devices, which require specialized manufacturing expertise. Increasing outsourcing of end-to-end device production by OEMs to contract manufacturers allows companies to reduce capital expenditure, accelerate time-to-market, and leverage advanced manufacturing technologies.

Therapeutic Area Insights

On the basis of the therapeutic area, the market is segmented into cardiovascular devices, orthopedic devices, ophthalmic devices, respiratory devices, surgical instruments, dental, and others. The cardiovascular devices segment captured the largest revenue share in the global therapeutic device contract manufacturing market. The dominance is due to the high prevalence of cardiovascular diseases worldwide, including heart failure, coronary artery disease, and arrhythmia, which is driving the demand for devices such as stents, pacemakers, heart valves, and catheters.

On the other hand, the ophthalmic devices segment is expected to experience significant growth during the forecast period. The growth of the market is due to the rising prevalence of eye-related disorders, including cataracts, glaucoma, macular degeneration, and diabetic retinopathy, particularly in aging populations. Increasing demand for advanced corrective and surgical devices, such as intraocular lenses, ophthalmic surgical instruments, and diagnostic imaging tools, is further fueling market expansion.

End-use Insight

On the basis of end use, the market is segmented into original equipment manufacturers (OEMS), pharmaceutical & biopharmaceutical companies, and others. The original equipment manufacturers (OEMs) segment held the largest market share in 2024. The growth of the segment is due to the high reliance of medical device companies on contract manufacturing for cost-efficient and scalable production. OEMs often outsource manufacturing to leverage the advanced technological capabilities, regulatory expertise, and quality assurance processes offered by specialized CMOs. This allows them to focus on core activities such as research, development, and marketing, while ensuring timely product launch and market expansion.

Furthermore, the pharmaceutical & biopharmaceutical companies’ segment is expected to grow at a significant CAGR during the forecast period. The segment is driven by the increasing integration of therapeutic devices with drug delivery systems, such as infusion pumps, insulin pens, and combination products, which require specialized manufacturing capabilities. Moreover, rising R&D activities and product pipelines in the pharmaceutical and biopharmaceutical sectors are creating demand for contract manufacturers to produce high-quality, compliant therapeutic devices at scale.

Regional Insights

North America therapeutic device contract manufacturing market is projected to register a significant CAGR during the forecast period. This can be attributed to technological advancements, growing demand for cutting-edge medical devices, presence of established healthcare, and increasing requirements for outsourcing among medical device companies to reduce operational costs, which is expected to drive efficiency, innovation and save cost for R&D. Moreover, there is increasing adoption of technology such as 3D printing, automation, robotics, and AI-driven processes for high maintenance and efficient systems has led rise in the need for therapeutic device contract manufacturing services.

U.S. Therapeutic Device Contract Manufacturing Market Trends

The therapeutic device contract manufacturing market in the U.S. held the largest share in 2024. In the U.S., the medical device industry makes a range of medical device products. It plays a crucial role in developing new medical technologies that can improve the ability to diagnose and treat various diseases. The growing number of OEMs outsourcing medical device manufacturing, the increasing need for innovative drug options, escalating disease prevalence, the surge in partnerships, and the presence of diversified companies that are mainly engaged in the research and development of new devices for specific therapeutic areas have led to a rise in requirements for services.

Europe Therapeutic Device Contract Manufacturing Market Trends

The therapeutic device contract manufacturing market in Europe is expected to grow significantly due to the rising demand for biopharmaceutical products and the increasing focus on optimizing resources & costs, facilitating a greater emphasis on innovation capabilities, further fueling medical device production. Moreover, most contract manufacturers adopt advanced technologies for medical device production, assembly, and related development, benefiting from the latest technology.

Germany therapeutic device contract manufacturing market held the largest share in 2024. The market in Germany is driven by medical technology and the presence of established, small, and medium-sized companies or sub-groups of larger companies. In addition, stringent regulations and evolving standards require contract manufacturers to adopt quality management systems that adhere to proper manufacturing practices, ensuring compliance and patient safety.

The therapeutic device contract manufacturing market in the UK is anticipated to grow over the forecast period. This growth is primarily due to the growing need for contract manufacturing for efficient and effective medical device production to reduce the time to market, further fueling the market. Besides, these CMOs mostly offer regulated services for medical devices, further providing quality assurance, maintaining production costs, and ensuring quality and patient safety. Such factors are anticipated to drive the market.

Asia Pacific Therapeutic Device Contract Manufacturing Market Trends

The therapeutic device contract manufacturing market in Asia Pacific held the largest share of 37.90% in 2024. This growth can be attributed to various factors, such as rising healthcare expenditure and the availability of several opportunities in this region, especially in Japan, China, and India. In Asia Pacific, the market is expected to grow as it is one of the best options for the medical device industry. The region is emerging as a hub for outsourcing drug discovery activities owing to the lower costs and favorable regulatory environment.

China's therapeutic device contract manufacturing market held the largest share in 2024. The country is one of the major hubs for medical device outsourcing as it supports cost-efficient manufacturing, and the availability of a skilled workforce endorses the production of complex medical devices. Hence, outsourcing services has become one of the most favored strategies in the country.

The therapeutic device contract manufacturing market in Japan, the second-largest regional market, is expected to provide a robust opportunity for therapeutic device contract manufacturing services, further driving the market. The country has an aging population and a growing incidence of various diseases, which has led to a rise in the demand for market services. Furthermore, the dependence on CMO industry players is expected to propel the demand for medical device contract manufacturing. In addition, government healthcare programs and policies to control pricing are anticipated to increase the demand for therapeutic device contract manufacturing in this region.

Key Therapeutic Device Contract Manufacturing Companies Insights

Key players operating in the therapeutic device contract manufacturing market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Recent Developments

• In August 2025, Thermo Fisher Scientific announced it to open a 375,000-square-foot manufacturing center of excellence in Mebane, North Carolina. This facility is expected to produce at least 40 million laboratory pipette tips per week, enhancing the company's ability to support U.S.-based pharmaceutical and biotech customers.

• In April 2025, FLEX LTD. announced to significantly increased in production capacity for data center power products at its advanced manufacturing facility in Columbia, South Carolina. This expansion aims to meet the rising power infrastructure demands of the AI era.

Therapeutic Device Contract Manufacturing Market